Source:http://linkedlifedata.com/resource/pubmed/id/18549648
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2008-6-13
|
pubmed:abstractText |
This study was aimed to investigate the effect of artificial antigen-presenting cells (aAPCs) on inducing activation and proliferation of specific T-lymphocytes through stimulating biological function of dendritic cells with aAPCs in vitro. The specific antigen of chronic myeloid leukemia CML-28 was screened as objective antigen peptide by using magnetic microbeads as vector; the CML-28 epitope sequence (Vltfaldsv) was obtained by antigen epitope prediction software; this epitope was coupled with MHC molecule and used as first signal molecule, the B7-1 molecule was used as second signal molecule; these 2 molecules simultaneously were loaded onto surface of magnetic microbeads so as to contract aAPC complex. The bone marrow mononuclear cells were derived from HLA-A2(+) healthy bone marrow donors, CD8(+) T lymphocytes were screened and co-cultured with aAPC complex. During culture the 5, 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) was added and proliferation of T-lymphocytes was detected by CPSE and proliferation level of specific T lymphocytes was detected by flow cytometry. The results showed that the proliferation level of CML-28 specific T lymphocytes obviously increased in experimental group, average level was 17.34 +/- 0.65%, while average level in control was 2.25 +/- 0.43%, there was significant difference between them (p < 0.01). It is concluded that the aAPC complex can mimic human APCs in vitro, and stimulate activation and proliferation of CD8(+) specific T lymphocytes.
|
pubmed:language |
chi
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
1009-2137
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
655-8
|
pubmed:meshHeading |
pubmed-meshheading:18549648-Adolescent,
pubmed-meshheading:18549648-Adult,
pubmed-meshheading:18549648-Antigen Presentation,
pubmed-meshheading:18549648-Antigen-Presenting Cells,
pubmed-meshheading:18549648-Antigens, Neoplasm,
pubmed-meshheading:18549648-Biomimetics,
pubmed-meshheading:18549648-CD8-Positive T-Lymphocytes,
pubmed-meshheading:18549648-Female,
pubmed-meshheading:18549648-HLA-A2 Antigen,
pubmed-meshheading:18549648-Humans,
pubmed-meshheading:18549648-Leukemia, Myelogenous, Chronic, BCR-ABL Positive,
pubmed-meshheading:18549648-Lymphocyte Activation,
pubmed-meshheading:18549648-Male,
pubmed-meshheading:18549648-Middle Aged,
pubmed-meshheading:18549648-Tissue Donors,
pubmed-meshheading:18549648-Young Adult
|
pubmed:year |
2008
|
pubmed:articleTitle |
[Activation of specific T lymphocyte induced by artificial antigen presenting cell complex in vitro].
|
pubmed:affiliation |
Deparment of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, Hubei Province, China. MHW555@21CN.COM
|
pubmed:publicationType |
Journal Article,
English Abstract,
Research Support, Non-U.S. Gov't
|